MARKET

MCADR

MCADR

MOUNTAIN CREST
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7750
+0.0300
+4.03%
Closed 16:00 09/24 EDT
OPEN
0.7400
PREV CLOSE
0.7450
HIGH
0.7750
LOW
0.7500
VOLUME
1.86K
TURNOVER
--
52 WEEK HIGH
1.050
52 WEEK LOW
0.2695
MARKET CAP
5.86M
P/E (TTM)
-3874.5000
1D
5D
1M
3M
1Y
5Y
BRIEF-Better Therapeutics Expects Pivotal Trial Of BT-001 In Type 2 Diabetes To Be Fully Enrolled In Q4 2021
reuters.com · 09/09 12:09
Better Therapeutics To Go Public Via Mountain Crest SPAC Deal
Benzinga · 04/07 17:31
BRIEF-Better Therapeutics To Go Public via Merger with Mountain Crest Acquisition Corp II
reuters.com · 04/07 12:08
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MCADR. Analyze the recent business situations of MOUNTAIN CREST through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About MCADR
Mountain Crest Acquisition Corp II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to pursue prospective targets that are in North America. The Company has not identified any specific business combination.

Webull offers kinds of Mountain Crest Acquisition Corp II stock information, including NASDAQ:MCADR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MCADR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MCADR stock methods without spending real money on the virtual paper trading platform.